Coluracetam is a nootropic that was derived from racetam, although very distinct from other compounds like Piracetam and Aniracetam. Coluracetam appears to interact with a process known as high affinity choline uptake, which is the rate-limiting step of drawing choline into a neuron for synthesis into the neurotransmitter acetylcholine. Studies show that Coluracetam shows the greatest potential in treating both general anxiety and clinical depression. Other studies show that the compound also shows promise in the treatment of optic nerve and retinal injury. Currently there have not been any negative side effects or toxicity reported with use.
|Chemical Names||Coluracetam; 135463-81-9; N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide; MKC-231; UNII-V6FL6O5GR7; V6FL6O5GR7;|
|Molecular Weight||341.40422 g/mol|